Suhrad Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 277.86%
- Profit Growth 16435.07%
- Ebitda 16619.00%
- Net Worth 1185.60%
- Total Assets 1478.24%
About Suhrad Life Science
Suhrad Life Science Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 August 2018 (Six years and five months 26 days old ). Its registered office is in Ankleshwar, Gujarat, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prafulbhai Bharadiya and Yash Bharadia serve as directors at the Company.
Company Details
- Location
Ankleshwar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304GJ2018PTC103754
- Company No.
103754
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Suhrad Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prafulbhai Bharadiya  | Director | 28-Aug-2018 | Current |
| Yash Bharadia | Director | 21-Nov-2018 | Current |
Financial Performance of Suhrad Life Science.
Suhrad Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 277.86% increase. The company also saw a substantial improvement in profitability, with a 16435.07% increase in profit. The company's net worth Soared by an impressive increase of 1185.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suhrad Life Science?
In 2023, Suhrad Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ray Colourants Private LimitedPrafulbhai Bharadiya and Yash Bharadia are mutual person
- Camorra Industries Private Limited
Prafulbhai Bharadiya and Yash Bharadia are mutual person
- Crypton Pigments Private Limited
Yash Bharadia is a mutual person
- Dragnet Chemicals Private Limited
Yash Bharadia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Suhrad Life Science?
Unlock and access historical data on people associated with Suhrad Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suhrad Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suhrad Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
